Cargando…
Proofs for PLOS ONE Paper : Does Pharmaceutical Pricing Transparency Matter? Examining Brazil’s Public Procurement System
BACKGROUND: We review procurement and pricing transparency practices for pharmaceutical products. We specifically focus on Brazil and examine its approach to increasing pricing transparency, with the aim of determining the level of effectiveness in lower prices using a tool (Banco de Preços em Saúde...
Autores principales: | Kohler, Jillian Clare, Mitsakakis, Nicholas, Saadat, Faridah, Byng, Danalyn, Martinez, Martha Gabriela |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4523918/ https://www.ncbi.nlm.nih.gov/pubmed/26238110 http://dx.doi.org/10.1186/s12992-015-0118-8 |
Ejemplares similares
-
The risk of corruption in public pharmaceutical procurement: how anti-corruption, transparency and accountability measures may reduce this risk
por: Kohler, Jillian Clare, et al.
Publicado: (2020) -
The Urgent Need for Transparent and Accountable Procurement of Medicine and Medical Supplies in Times of COVID-19 Pandemic
por: Kohler, Jillian Clare, et al.
Publicado: (2020) -
PHARMACEUTICAL PRICING IN EMERGING MARKETS: EFFECTS OF INCOME, COMPETITION, AND PROCUREMENT
por: Danzon, Patricia M, et al.
Publicado: (2015) -
PLoS Medicine and the Pharmaceutical Industry
Publicado: (2006) -
Collective pharmaceutical procurement in China may have unintended consequences in supply and pricing
por: Jiang, Shan, et al.
Publicado: (2020)